author-photo

Acy Telles de Souza Quixadá

Federal University of Ceará

12

Papers

49

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?

2019 Hematology, Transfusion and Cell Therapy
Show All
- Source
- Cite
- Save
Citations (3)
Avaliação das alterações hematológicas no tratamento da leucemia mielóide crônica em pacientes com uso de inibidores de tirosina quinase

2016
Show All
- Source
- Cite
- Save
Citations (0)
Pancytopenia during tyrosine kinase inhibitor treatment – coexistence of chronic myeloid leukemia and visceral leishmaniasis: a case report

2016 Journal of Medical Case Reports
Show All
- Source
- Cite
- Save
Citations (1)
Chronic myeloid leukemia: an overview of the determinants of effectiveness and therapeutic response in the first decade of treatment with imatinib mesylate in a Brazilian hospital.

2013 Revista Brasileira De Hematologia E Hemoterapia
Show All
- Source
- Cite
- Save
Citations (5)
Adherence to treatment with imatinib in chronic myeloid leukemia: a study of the first decade of responses obtained at a Brazilian hospital

2013 Revista Brasileira De Hematologia E Hemoterapia
Show All
- Source
- Cite
- Save
Citations (10)
Serum concentrations of nitrite and malondialdehyde as markers of oxidative stress in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors

2012 Revista Brasileira De Hematologia E Hemoterapia
Show All
- Source
- Cite
- Save
Citations (12)
Molecular Response to Nilotinib 600 Mg Bid for Imatinib Resistance in a Patient with CML AP with Multiple Mutations Including G250E and E255K.

2009 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Efeito da bomba de infuso de solues sobre o grau de hemlise em concentrados de hemcias

2007 Revista Brasileira De Hematologia E Hemoterapia
Show All
- Source
- Cite
- Save
Citations (0)
Observacional Study for Evaluation of Quality of Life in Patients with Chronic Myeloid Leukemia (CML) in Use of Gleevec® (Imatinib Mesilate).

2004 Blood
Show All
- Source
- Cite
- Save
Citations (2)